Shire Settles Patent Row With Sandoz Over Generic Intuniv
Pharmaceuticals manufacturer Shire PLC has settled its patent infringement claims against Sandoz Inc. over the company's attempt to develop a generic form of Intuniv, an attention deficit hyperactivity disorder drug, according to an...To view the full article, register now.
Already a subscriber? Click here to view full article